Fiche publication
Date publication
février 2017
Journal
The Journal of clinical endocrinology and metabolism
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence
,
Pr PETIT Jean-Michel
,
Pr VERGES Bruno
Tous les auteurs :
Petit JM, Cercueil JP, Loffroy R, Denimal D, Bouillet B, Fourmont C, Chevallier O, Duvillard L, Vergès B
Lien Pubmed
Résumé
Nonalcoholic fatty liver disease is very frequent in type 2 diabetes, with increased risk of further development of liver fibrosis. Animal studies have shown that GLP-1 receptor agonists may reduce liver lipogenesis. However, data in humans are scarce.
Mots clés
Adipose Tissue, drug effects, Adult, Aged, Diabetes Mellitus, Type 2, complications, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, administration & dosage, Liraglutide, administration & dosage, Magnetic Resonance Spectroscopy, methods, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, drug therapy, Prognosis, Prospective Studies, Weight Loss, physiology
Référence
J. Clin. Endocrinol. Metab.. 2017 Feb;102(2):407-415
